Back to list

Phase II Trial of Ixazomib combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma

geo / GSE306473

Dataset

Provider: GEO
Type: bulk
Organism: Homo sapiens (tax 9606)
Format / file: archive_table — GSE306473_RAW.tar (414 MB)
Matrix: 15 samples
Source page: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306473
Download URL: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE306nnn/GSE306473/suppl/GSE306473_RAW.tar

DOIs

None

PubMed IDs

Accessions

Not in ASAP yet.